Hydroquinone

Hydroquinone

SCHEMBL2468660

I.Oc1ccc(O)cc1

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Hydroquinone. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydroquinone SCHEMBL15516 0.94 — —
Hydroquinone SCHEMBL460669 0.94 ALOX15 (1.00) —
Hydroquinone SCHEMBL11511669 0.94 ALOX15 (1.00) —
Hydroquinone SCHEMBL11550543 0.89 — —
Hydroquinone SCHEMBL5051994 0.89 CA3 (0.89) —
Hydroquinone SCHEMBL7050995 0.89 — —
Hydroquinone SCHEMBL1549929 0.89 — —
Hydroquinone SCHEMBL20580953 0.89 — —
Hydroquinone SCHEMBL10531803 0.89 ALOX15 (0.89) —
Hydroquinone SCHEMBL1643593 0.89 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3765220-B1 PROCESS FOR PRODUCING ATOMIC QUANTUM CLUSTERS NANOGAP SUB NM POWDER S A (ES) 2022-08-17 — — EP claimed
EP-2371398-B1 MEDICAL SUPPLIES AND METHOD OF PRODUCING THE SAME PROSTEC CO LTD (JP) 2013-05-15 — — EP claimed
US-12616576-B2 Methods of modifying the porous surface of implants BIOMET MANUFACTURING, LLC (US) 2026-05-05 — — US disclosed
US-12605488-B2 Surface treatment methods for cementless implantable medical devices DURAHIP, LLC (US) 2026-04-21 — — US disclosed
US-20240207482-A1 SURFACE TREATMENT METHODS FOR CEMENTLESS IMPLANTABLE MEDICAL DEVICES DURAHIP, LLC 2024-06-27 — — US disclosed
US-20220331115-A1 METHODS OF MODIFYING THE POROUS SURFACE OF IMPLANTS BIOMET MFG LLC (US) 2022-10-20 — — US disclosed
EP-3765220-B1 PROCESS FOR PRODUCING ATOMIC QUANTUM CLUSTERS NANOGAP SUB NM POWDER S A (ES) 2022-08-17 — — EP disclosed
US-11395740-B2 Methods of modifying the porous surface of implants BIOMET MANUFACTURING, LLC (US) 2022-07-26 — — US disclosed
EP-3981444-A1 METHODS OF MODIFYING THE POROUS SURFACE OF IMPLANTS Biomet Manufacturing, LLC (US) 2022-04-13 — — EP disclosed
US-20210186703-A1 METHODS OF MODIFYING THE POROUS SURFACE OF IMPLANTS BIOMET MFG LLC (US) 2021-06-24 — — US disclosed
EP-3391915-B1 METHODS OF MODIFYING THE POROUS SURFACE OF IMPLANTS BIOMET MFG LLC (US) 2021-04-14 — — EP disclosed
US-20180243483-A1 MEDICAL SUPPLIES AND METHOD OF PRODUCING THE SAME PROSTEC CO LTD (JP) 2018-08-30 — — US disclosed
US-9889231-B2 Medical supplies and method of producing the same PROSTEC CO., LTD. (JP) 2018-02-13 — — US disclosed
CN-102281906-B Medical part and manufacturing method therefor PROSTEC CO LTD 2014-08-27 — — CN disclosed
US-20130240365-A1 MEDICAL SUPPLIES AND METHOD OF PRODUCING THE SAME PROSTEC CO., LTD. (JP) 2013-09-19 — — US disclosed
EP-2371398-B1 MEDICAL SUPPLIES AND METHOD OF PRODUCING THE SAME PROSTEC CO LTD (JP) 2013-05-15 — — EP disclosed
US-20110313539-A1 MEDICAL SUPPLIES AND METHOD OF PRODUCING THE SAME PROSTEC CO., LTD. (JP) 2011-12-22 — — US disclosed
CN-102281906-A Medical part and manufacturing method therefor — 2011-12-14 — — CN disclosed
EP-2371398-A1 MEDICAL PART AND MANUFACTURING METHOD THEREFOR Prostec Co., Ltd. (JP) 2011-10-05 — — EP disclosed
US-6384270-B1 ACETYLATION OF ETHYNYL-RETRO-.ALPHA.-IONOL, ISOMERIZATION OF THE ACETATE TO ALLENE ACETATE AND HYDROLYZING IT TO AN ALDEHYDE AVENTIS ANIMAL NUTRITION, S.A. (FR) 2002-05-07 — — US disclosed
Send feedback